Lycia Therapeutics

1 follower

‌

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Aetna Wun Trombley

President & CEO

Aetna Wun Trombley

Collapse

Steve Staben

Chief Scientific Officer

Winsome Chung

VP, Finance

Larry Rozsnyai

Vice President, Intellectual Property

Nadia Tchao

Executive Director, Head of Translational Medicine & Early Development

Darrin Lindhout

Head of Biologics

Patricia Chang

Associate Director, Project And Alliance Management

Teams

+13

Scientific Research Team

16 members

Directors Team

6 members

Research and Development

5 members

Advisory Team

5 members

Leadership Team

2 members

Similar companies

SenesTech

2 followers

Kyverna Therapeutics

6 followers

Day One Biopharmaceuticals

1 follower

Ventyx Biosciences

1 follower

Abcuro

1 follower

Odyssey Therapeutics

2 followers

Thermo Fisher Scientific

172 followers

Genentech

158 followers

Gilead Sciences

132 followers

Biogen

118 followers

Regeneron

100 followers

Explore companies

��������